- Home
- SMTI vs LXEO Comparison
SMTI vs LXEO Comparison
Compare SMTI & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- LXEO
- Stock Information
- Founded
- SMTI 1982
- LXEO 2017
- Country
- SMTI United States
- LXEO United States
- Employees
- SMTI N/A
- LXEO N/A
- Industry
- SMTI Medical/Dental Instruments
- LXEO
- Sector
- SMTI Health Care
- LXEO
- Exchange
- SMTI Nasdaq
- LXEO Nasdaq
- Market Cap
- SMTI 288.2M
- LXEO 314.1M
- IPO Year
- SMTI N/A
- LXEO 2023
- Fundamental
- Price
- SMTI $34.39
- LXEO $7.81
- Analyst Decision
- SMTI Buy
- LXEO Strong Buy
- Analyst Count
- SMTI 1
- LXEO 7
- Target Price
- SMTI $44.00
- LXEO $22.14
- AVG Volume (30 Days)
- SMTI 24.7K
- LXEO 347.0K
- Earning Date
- SMTI 11-12-2024
- LXEO 11-21-2024
- Dividend Yield
- SMTI N/A
- LXEO N/A
- EPS Growth
- SMTI N/A
- LXEO N/A
- EPS
- SMTI N/A
- LXEO N/A
- Revenue
- SMTI $72,410,222.00
- LXEO N/A
- Revenue This Year
- SMTI $26.97
- LXEO N/A
- Revenue Next Year
- SMTI $18.91
- LXEO N/A
- P/E Ratio
- SMTI N/A
- LXEO N/A
- Revenue Growth
- SMTI 21.42
- LXEO N/A
- 52 Week Low
- SMTI $26.00
- LXEO $7.54
- 52 Week High
- SMTI $43.25
- LXEO $22.33
- Technical
- Relative Strength Index (RSI)
- SMTI 64.02
- LXEO 40.96
- Support Level
- SMTI $32.91
- LXEO $7.54
- Resistance Level
- SMTI $34.03
- LXEO $8.43
- Average True Range (ATR)
- SMTI 1.39
- LXEO 0.63
- MACD
- SMTI 0.24
- LXEO -0.12
- Stochastic Oscillator
- SMTI 100.00
- LXEO 15.46
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.